Clinical Observation on Effect of Toujie Quwen Granules in Treatment of COVID-19
10.13422/j.cnki.syfjx.20201314
- VernacularTitle:透解祛瘟颗粒治疗新型冠状病毒肺炎临床观察
- Author:
Xiao-xia FU
1
;
Lu-ping LIN
1
;
Xing-hua TAN
1
Author Information
1. Guangzhou Eighth People's Hospital， Guangzhou 510440， China
- Publication Type:Research Article
- Keywords:
Toujie Quwen granules;
coronavirs disease-2019（COVID-19）;
clinical study;
pneumonia;
light type;
ordinary type
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2020;26(12):44-48
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the clinical efficacy of traditional Chinese medicine（TCM） Toujie Quwen granules in the treatment of coronavirs disease-2019（COVID-19） in the early stage, and its effect on relevant inflammatory index expression of COVID-19. Method:A total of 65 COVID-19 cases were diagnosed and divided into 2 groups: the treatment group （n=32） and the control group （n=33）. Before and after treatment，TCM syndrome score，WBC，LYM，LYM%，NEU%，PCT，CRP and D-dimer were compared. Result:After 10 days of treatment，the TCM syndrome score of the treatment group was significantly reduced（P<0.05），while the absolute value of lymphocyte was up-regulated，with statistically significant differences（P<0.05）， according to the inter-group comparison, there were statistically significant differences in the absolute value of LYM and NEU%（P<0.05）. There was no significant difference in WBC count and LYM%. The levels of CRP，PCT and D-dimer in the two groups were reduced after treatment，with statistically significant differences between two groups （P<0.05）. After treatment，the differences of CRP and PCT was statistically significant between both groups（P<0.05），but the difference in D-dimer was not statistically significant. There was no difference in the effect of chest CT examination between the both groups. Conclusion:The clinical syndrome and inflammatory particles of COVID-19 can be alleviated by early and timely use of Toujie Quwen granules.
